<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=384506&amp;fmt=gif">
Skip to content
    June 10, 2022

    Recorded Webinar: COVID Moonshot — A Collaborative Approach to Antiviral Discovery

    CDD Webinar Recorded Live Logo

    COVID Moonshot - A Collaborative Approach to Antiviral Discovery

    Recorded live June 9, 2022

    In the early days of the COVID-19 pandemic, a group of scientists hailing from academic and industrial organizations around the world came together with the ambitious goal of discovering an antiviral against the virus. Two years later, the COVID Moonshot consortium has identified multiple compounds to be entered into preclinical trial.

    Join this webinar to hear behind-the-scene stories of COVID Moonshot and learn how this non-profit, open-science project was able to achieve significant results with limited resources.

     

     

    Featuring these leading scientists...

    Monalisa Chatterji

    Monalisa Chatterji, PhD

    Cofounder,
    Sekkei Bio Pvt. Ltd.

    Monalisa Chatterji has 20+ years of experience in both small molecules and biologics discovery and development. She is the innovator for TBA-7371 (anti-infective) and T1h (Mab) at AstraZeneca and Biocon, respectively. 

    For the last three years, Dr. Chatterji served as Senior Program Officer at Gates Foundation where she supported collaborative COVID research with WHO, DNDi, and CARE, and was involved in the Access to COVID-19 Tools (ACT) Accelerator. 

    Dr. Chatterji received Integrated M.S. & Ph.D. from Indian Institute of Science, India and conducted post-doctoral research at Yale University. She was recognized among 75 women by the government of India in 2022 for "excellence in the field of STEAM".

    Ed Griffen

    Ed Griffen, PhD

    Technical Director, MedChemica Ltd

    Ed Griffen is a Technical Director at MedChemica Limited and leads the Design Team in the COVID Moonshot.
    His interests are in medicinal chemistry, particularly in anti-infectives and the development of new approaches focused on explainable AI methods to improve and accelerate lead generation and optimization.

    Prior to that he was a Team Leader and Principal Scientist at AstraZeneca based in the UK working in anti-infectives, oncology and computational chemistry.

    Dr. Griffen received a B.Sc. and Ph.D. from Imperial College London, and undertook a post-doctoral fellowship with Professor Victor Snieckus at the University of Waterloo.

    Annette-von-Delft-200px

    Annette von Delft, MD, PhD

    Translational Scientist, University of Oxford

    Annette von Delft joined University of Oxford in 2018 as a translational scientist with a focus on inflammation and immunity. She is currently driving the COVID Moonshot open science drug discovery project in collaboration with multiple international partners. 

    Dr. von Delft trained as a medical doctor at University of Leipzig and received her D.Phil in Clinical Medicine at the University of Oxford. Her project focused on HCV T cell immunology and vaccine development under the supervision of Prof Eleanor Barnes. She then completed her medical foundation program at Oxford University Hospitals

    Tag(s): CDD Blog , Webinars

    Other posts you might be interested in

    View All Posts
    CDD Blog
    3 min   May 18, 2024
    Upcoming Webinar: Targeted Protein Degradation - New Modalities and Design Technologies
    Read More
    CDD Vault Updates
    4 min   May 17, 2024
    CDD Vault Update (May 2024 #2): View Assay Ontologies, SureChEMBL Deep Learning Similarity Search, Merge/Split ELN Table Cells, File Previews in ELN
    Read More
    CDD Vault Updates
    8 min   May 10, 2024
    CDD Vault Update (May 2024): Overlay & Customize Dose-Response Plots, Bioisosteric Compound Suggestions, Parser Updates, and Quickly Search Related Protocols
    Read More